{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:29:57Z","timestamp":1793831397443,"version":"4.6.1"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,4,27]],"date-time":"2022-04-27T00:00:00Z","timestamp":1651017600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,27]],"date-time":"2022-04-27T00:00:00Z","timestamp":1651017600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2022,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>Despite the absorption of oral thyroxine (T4) occurs in the small bowel, several patients with gastric disorders show an increased need for T4. In vitro evidence suggested that medium pH variations interfere with T4 dissolution. This study was aimed at finding the proof of concept of a direct relationship between the minimal effective dose of T4 and the actual gastric juice pH.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Patients and methods<\/jats:title>\n                <jats:p>Among 311 consecutively thyroxine-treated patients, 61 bearing Hashimoto\u2019s thyroiditis (52\u2009F\/9\u2009M; median age\u2009=\u200951 years) who complained persistent dyspepsia and\/or upper abdominal symptoms following a noninvasive workup for gastrointestinal disorders, underwent EGDS with multiple biopsies and gastric juice pH measurement. All patients accepted to take thyroxine in fasting conditions, abstaining from eating or drinking for one hour.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Thyroxine requirement increased along with the rising gastric pH (<jats:italic>\u03c1<\/jats:italic>\u2009=\u20090.4229; <jats:italic>p<\/jats:italic>\u2009=\u20090.0007). A multivariate analysis revealed that gastric pH was, beside body mass index, the far more important independent variable in determining the effective dose of T4 (<jats:italic>p<\/jats:italic>\u2009=\u20090.001). The ROC curve revealed that the pH threshold for an increased thyroxine requirement was at 2.28, being the AUC by 78%. Subdividing patients by the histologic findings, it appeared a significant increase (<jats:italic>p<\/jats:italic>\u2009=\u20090.0025) along with the progressive damage of gastric mucosa.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The in vivo measurement of gastric pH highlighted its key role in determining the minimal effective dose of oral T4 and may explain the interference of food, of some drugs and gut disorders on levothyroxine treatment<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s12020-022-03056-1","type":"journal-article","created":{"date-parts":[[2022,4,27]],"date-time":"2022-04-27T19:03:18Z","timestamp":1651086198000},"page":"102-111","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Levothyroxine treatment and gastric juice pH in humans: the proof of concept"],"prefix":"10.1007","volume":"77","author":[{"given":"Camilla","family":"Virili","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Bruno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Giulia","family":"Santaguida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucilla","family":"Gargano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Stramazzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corrado","family":"De Vito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Cicenia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Scalese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Porowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carola","family":"Severi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0661-1649","authenticated-orcid":false,"given":"Marco","family":"Centanni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,27]]},"reference":[{"issue":"3","key":"3056_CR1","doi-asserted-by":"publisher","first-page":"799803","DOI":"10.1210\/jc.2015-3695","volume":"101","author":"PW Ladenson","year":"2016","unstructured":"P.W. Ladenson, Precision medicine comes to thyroidology. J. Clin. Endocrinol. Metab. 101(3), 799803 (2016). https:\/\/doi.org\/10.1210\/jc.2015-3695","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"3056_CR2","unstructured":"http:\/\/clincalc.com\/DrugStats\/Top200Drugs.aspx. The Top 200 of 2021 provided by the ClinCalc DrugStats Database. Accessed 15 Mar 2021"},{"issue":"12","key":"3056_CR3","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1089\/thy.2014.0028","volume":"24","author":"J Jonklaas","year":"2014","unstructured":"J. Jonklaas, A.C. Bianco, A.J. Bauer, K.D. Burman, A.R. Cappola, F.S. Celi, D.S. Cooper, B.W. Kim, R.P. Peeters, M.S. Rosenthal, A.M. Sawka, American Thyroid Association Task Force on Thyroid Hormone Replacement. Guidelines for the treatment of hypothyroidism: prepared by the American Thyroid Association task force on thyroid hormone replacement. Thyroid 24(12), 1670\u20131751 (2014). https:\/\/doi.org\/10.1089\/thy.2014.0028","journal-title":"Thyroid"},{"issue":"6","key":"3056_CR4","doi-asserted-by":"publisher","first-page":"988","DOI":"10.4158\/EP12280.GL","volume":"18","author":"JR Garber","year":"2012","unstructured":"J.R. Garber, R.H. Cobin, H. Gharib, J.V. Hennessey, I. Klein, J.I. Mechanick, R. Pessah-Pollack, P.A. Singer, K.A. Woeber, American Association Of Clinical Endocrinologists And American Thyroid Association Taskforce On Hypothyroidism In Adults. Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Endocr. Pract. 18(6), 988\u20131028 (2012). https:\/\/doi.org\/10.4158\/EP12280.GL","journal-title":"Endocr. Pract."},{"issue":"3","key":"3056_CR5","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1210\/er.2013-1083","volume":"35","author":"B Biondi","year":"2014","unstructured":"B. Biondi, L. Wartofsky, Treatment with thyroid hormone. Endocr. Rev. 35(3), 433\u2013512 (2014). https:\/\/doi.org\/10.1210\/er.2013-1083","journal-title":"Endocr. Rev."},{"key":"3056_CR6","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1177\/0004563216642255","volume":"53","author":"V Eligar","year":"2016","unstructured":"V. Eligar, P.N. Taylor, O.E. Okosieme, G.P. Leese, C.M. Dayan, Thyroxine replacement: a clinical endocrinologist\u2019s viewpoint. Ann. Clin. Biochem. 53, 421\u2013433 (2016). https:\/\/doi.org\/10.1177\/0004563216642255","journal-title":"Ann. Clin. Biochem."},{"issue":"25","key":"3056_CR7","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1056\/NEJMcp1709318","volume":"378","author":"B Biondi","year":"2018","unstructured":"B. Biondi, D.S. Cooper, Subclinical Hyperthyroidism. N. Engl. J. Med. 378(25), 2411\u20132419 (2018). https:\/\/doi.org\/10.1056\/NEJMcp1709318","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"3056_CR8","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.beem.2011.12.004","volume":"26","author":"B Biondi","year":"2012","unstructured":"B. Biondi, Natural history, diagnosis and management of subclinical thyroid dysfunction. Best. Pract. Res. Clin. Endocrinol. Metab. 26(4), 431\u2013446 (2012). https:\/\/doi.org\/10.1016\/j.beem.2011.12.004","journal-title":"Best. Pract. Res. Clin. Endocrinol. Metab."},{"issue":"11","key":"3056_CR9","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1016\/j.tet.2009.12.044","volume":"66","author":"SR Chemburkar","year":"2010","unstructured":"S.R. Chemburkar, K.C. Deming, R.E. Reddy, Chemistry of thyroxine: an historical perspective and recent progress on its synthesis. Tetrahedron 66(11), 1955\u20131962 (2010)","journal-title":"Tetrahedron"},{"issue":"37","key":"3056_CR10","doi-asserted-by":"publisher","first-page":"10833","DOI":"10.1002\/anie.201505281","volume":"54","author":"S Mondal","year":"2015","unstructured":"S. Mondal, G. Mugesh, Structure elucidation and characterization of different thyroxine polymorphs. Angew. Chem. Int. Ed. Engl. 54(37), 10833\u201310837 (2015). https:\/\/doi.org\/10.1002\/anie.201505281","journal-title":"Angew. Chem. Int. Ed. Engl."},{"issue":"3","key":"3056_CR11","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1089\/thy.1991.1.241","volume":"1","author":"MT Hays","year":"1991","unstructured":"M.T. Hays, Localization of human thyroxine absorption. Thyroid 1(3), 241\u2013248 (1991). https:\/\/doi.org\/10.1089\/thy.1991.1.241","journal-title":"Thyroid"},{"issue":"1","key":"3056_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0026-0495(77)90121-4","volume":"26","author":"KW Wenzel","year":"1977","unstructured":"K.W. Wenzel, H.E. Kirschsieper, Aspects of the absorption of oral L-thyroxine in normal man. Metabolism 26(1), 1\u20138 (1977). https:\/\/doi.org\/10.1016\/0026-0495(77)90121-4","journal-title":"Metabolism"},{"issue":"1","key":"3056_CR13","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1089\/thy.2017.0380","volume":"28","author":"IR Younis","year":"2018","unstructured":"I.R. Younis, M.A. Ahmed, K.D. Burman, O.P. Soldin, J. Jonklaas, Stable isotope pharmacokinetic studies provide insight into effects of age, sex, and weight on levothyroxine metabolism. Thyroid 28(1), 41\u201349 (2018). https:\/\/doi.org\/10.1089\/thy.2017.0380","journal-title":"Thyroid"},{"issue":"1","key":"3056_CR14","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1210\/jc.2004-1306","volume":"90","author":"F Santini","year":"2005","unstructured":"F. Santini, A. Pinchera, A. Marsili, G. Ceccarini, M.G. Castagna, R. Valeriano, M. Giannetti, D. Taddei, R. Centoni, G. Scartabelli, T. Rago, C. Mammoli, R. Elisei, P. Vitti, Lean body mass is a major determinant of levothyroxine dosage in the treatment of thyroid diseases. J. Clin. Endocrinol. Metab. 90(1), 124\u2013127 (2005). https:\/\/doi.org\/10.1210\/jc.2004-1306","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"22","key":"3056_CR15","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1111\/j.1365-2265.2006.02681.x","volume":"170","author":"N Bolk","year":"2010","unstructured":"N. Bolk, T.J. Visser, J. Nijman, I.J. Jongste, J.G.P. Tijssen, A. Berghout, Effects of evening vs morning levothyroxine intake: a randomized double-blind crossover trial. Arch. Intern. Med. 170(22), 1996\u20132003 (2010). https:\/\/doi.org\/10.1111\/j.1365-2265.2006.02681.x","journal-title":"Arch. Intern. Med."},{"issue":"5","key":"3056_CR16","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1111\/cen.14172","volume":"92","author":"X Pang","year":"2020","unstructured":"X. Pang, T. Pu, L. Xu, R. Sun, Effect of l-LT4 administration before breakfast vs at bedtime on hypothyroidism: a meta-analysis. Clin. Endocrinol. 92(5), 475\u2013481 (2020). https:\/\/doi.org\/10.1111\/cen.14172","journal-title":"Clin. Endocrinol."},{"issue":"1","key":"3056_CR17","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1210\/er.2018-00168","volume":"40","author":"C Virili","year":"2019","unstructured":"C. Virili, A. Antonelli, M.G. Santaguida, S. Benvenga, M. Centanni, Gastrointestinal malabsorption of thyroxine. Endocr. Rev. 40(1), 118\u2013136 (2019). https:\/\/doi.org\/10.1210\/er.2018-00168","journal-title":"Endocr. Rev."},{"issue":"12","key":"3056_CR18","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1007\/s40618-017-0706-y","volume":"40","author":"M Centanni","year":"2017","unstructured":"M. Centanni, S. Benvenga, I. Sachmechi, Diagnosis and management of treatment-refractory hypothyroidism: an expert consensus report. J. Endocrinol. Investig. 40(12), 1289\u20131301 (2017). https:\/\/doi.org\/10.1007\/s40618-017-0706-y","journal-title":"J. Endocrinol. Investig."},{"issue":"4","key":"3056_CR19","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1089\/thy.1995.5.249","volume":"5","author":"S Benvenga","year":"1995","unstructured":"S. Benvenga, L. Bartolone, S. Squadrito, F. Lo Giudice, F. Trimarchi, Delayed intestinal absorption of levothyroxine. Thyroid 5(4), 249\u2013253 (1995). https:\/\/doi.org\/10.1089\/thy.1995.5.249","journal-title":"Thyroid"},{"issue":"17","key":"3056_CR20","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1056\/NEJMoa043903","volume":"354","author":"M Centanni","year":"2006","unstructured":"M. Centanni, L. Gargano, G. Canettieri, N. Viceconti, A. Franchi, G. Delle Fave, B. Annibale, Thyroxine in goiter, Helicobacter pylori infection, and chronic gastritis. N. Engl. J. Med. 354(17), 1787\u20131795 (2006). https:\/\/doi.org\/10.1056\/NEJMoa043903","journal-title":"N. Engl. J. Med."},{"issue":"30","key":"3056_CR21","doi-asserted-by":"publisher","first-page":"10331","DOI":"10.3748\/wjg.v20.i30.10331","volume":"20","author":"E Lahner","year":"2014","unstructured":"E. Lahner, C. Virili, M.G. Santaguida, B. Annibale, M. Centanni, Helicobacter pylori infection and drugs malabsorption. World J. Gastroenterol. 20(30), 10331\u201310337 (2014). https:\/\/doi.org\/10.3748\/wjg.v20.i30.10331","journal-title":"World J. Gastroenterol."},{"issue":"2","key":"3056_CR22","first-page":"47","volume":"167","author":"OS Khraisha","year":"2015","unstructured":"O.S. Khraisha, M.M. Al-Madani, A.N. Peiris, T.K. Paul, Gastroparesis a novel cause of persistent thyroid stimulating hormone elevation in hypothyroidism. J. LA State Med. Soc. 167(2), 47\u201349 (2015)","journal-title":"J. LA State Med. Soc."},{"issue":"4","key":"3056_CR23","doi-asserted-by":"publisher","first-page":"345","DOI":"10.4158\/EP.13.4.345","volume":"13","author":"I Sachmechi","year":"2007","unstructured":"I. Sachmechi, D.M. Reich, M. Aninyei, F. Wibowo, G. Gupta, P.J. Kim, Effect of proton pump inhibitors on serum thyroid-stimulating hormone level in euthyroid patients treated with levothyroxine for hypothyroidism. Endocr. Pract. 13(4), 345\u2013349 (2007). https:\/\/doi.org\/10.4158\/EP.13.4.345","journal-title":"Endocr. Pract."},{"issue":"43","key":"3056_CR24","doi-asserted-by":"publisher","first-page":"5496","DOI":"10.3748\/wjg.v16.i43.5496","volume":"16","author":"PJ Lu","year":"2010","unstructured":"P.J. Lu, P.I. Hsu, C.H. Chen, M. Hsiao, W.C. Chang, H.H. Tseng, K.H. Lin, S.K. Chuah, H.C. Chen, Gastric juice acidity in upper gastrointestinal diseases. World J. Gastroenterol. 16(43), 5496\u20135501 (2010). https:\/\/doi.org\/10.3748\/wjg.v16.i43.5496","journal-title":"World J. Gastroenterol."},{"issue":"3","key":"3056_CR25","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.humpath.2004.12.008","volume":"36","author":"M Rugge","year":"2005","unstructured":"M. Rugge, R.M. Genta, Staging and grading of chronic gastritis. Hum. Pathol. 36(3), 228\u2013233 (2005). https:\/\/doi.org\/10.1016\/j.humpath.2004.12.008","journal-title":"Hum. Pathol."},{"issue":"2","key":"3056_CR26","doi-asserted-by":"publisher","first-page":"158","DOI":"10.5009\/gnl17063","volume":"12","author":"J Sung","year":"2018","unstructured":"J. Sung, N. Kim, J. Lee, Y.J. Hwang, H.W. Kim, J.W. Chung, J.W. Kim, D.H. Lee, Associations among gastric juice pH, atrophic gastritis, intestinal metaplasia and Helicobacter pylori infection. Gut Liver 12(2), 158\u2013164 (2018). https:\/\/doi.org\/10.5009\/gnl17063","journal-title":"Gut Liver"},{"issue":"6","key":"3056_CR27","doi-asserted-by":"publisher","first-page":"657","DOI":"10.3109\/00365521.2015.1019918","volume":"50","author":"PI Sipponen","year":"2015","unstructured":"P.I. Sipponen, H.I. Maaroos, Chronic gastritis. Scand. J. Gastroenterol. 50(6), 657\u2013667 (2015). https:\/\/doi.org\/10.3109\/00365521.2015.1019918","journal-title":"Scand. J. Gastroenterol."},{"key":"3056_CR28","doi-asserted-by":"publisher","first-page":"92","DOI":"10.3389\/fendo.2017.00092","volume":"8","author":"M Cellini","year":"2017","unstructured":"M. Cellini, M.G. Santaguida, C. Virili, S. Capriello, N. Brusca, L. Gargano, M. Centanni, Hashimoto\u2019s thyroiditis and autoimmune gastritis. Front Endocrinol. 8, 92 (2017). https:\/\/doi.org\/10.3389\/fendo.2017.00092","journal-title":"Front Endocrinol."},{"issue":"11","key":"3056_CR29","doi-asserted-by":"publisher","first-page":"3970","DOI":"10.1021\/mp400256h","volume":"10","author":"A Mitra","year":"2013","unstructured":"A. Mitra, F. Kesisoglou, Impaired drug absorption due to high stomach pH: a review of strategies for mitigation of such effect to enable pharmaceutical product development. Mol. Pharm. 10(11), 3970\u20133979 (2013). https:\/\/doi.org\/10.1021\/mp400256h","journal-title":"Mol. Pharm."},{"issue":"5","key":"3056_CR30","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1007\/s11095-017-2129-z","volume":"34","author":"D Markl","year":"2017","unstructured":"D. Markl, J.A. Zeitler, A review of disintegration mechanisms and measurement techniques. Pharm. Res. 34(5), 890\u2013917 (2017). https:\/\/doi.org\/10.1007\/s11095-017-2129-z","journal-title":"Pharm. Res."},{"issue":"1","key":"3056_CR31","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1023\/a:1018952415732","volume":"9","author":"CM Won","year":"1992","unstructured":"C.M. Won, Kinetics of degradation of levothyroxine in aqueous solution and in solid state. Pharm. Res. 9(1), 131\u2013137 (1992). https:\/\/doi.org\/10.1023\/a:1018952415732","journal-title":"Pharm. Res."},{"issue":"19","key":"3056_CR32","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1023\/a:1018952415732","volume":"373","author":"NJ Talley","year":"2015","unstructured":"N.J. Talley, A.C. Ford, Functional dyspepsia. N. Engl. J. Med. 373(19), 1853\u20131863 (2015). https:\/\/doi.org\/10.1023\/a:1018952415732","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"3056_CR33","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1111\/j.1365-2265.2007.03091.x","volume":"68","author":"R Sibilla","year":"2008","unstructured":"R. Sibilla, M.G. Santaguida, C. Virili, L. Gargano, S. Nardo, M. Della Guardia, N. Viceconti, A. Franchi, M. Centanni, Chronic unexplained anaemia in isolated autoimmune thyroid disease or associated with autoimmune related disorders. Clin. Endocrinol. 68(4), 640\u2013645 (2008). https:\/\/doi.org\/10.1111\/j.1365-2265.2007.03091.x","journal-title":"Clin. Endocrinol."},{"issue":"3","key":"3056_CR34","doi-asserted-by":"publisher","first-page":"E419","DOI":"10.1210\/jc.2011-1851","volume":"97","author":"C Virili","year":"2012","unstructured":"C. Virili, G. Bassotti, M.G. Santaguida, R. Iuorio, S.C. Del Duca, V. Mercuri, A. Picarelli, P. Gargiulo, L. Gargano, M. Centanni, Atypical celiac disease as cause of increased need for thyroxine: a systematic study. J. Clin. Endocrinol. Metab. 97(3), E419\u2013E422 (2012). https:\/\/doi.org\/10.1210\/jc.2011-1851","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"8","key":"3056_CR35","doi-asserted-by":"publisher","first-page":"E1454","DOI":"10.1210\/jc.2014-1217","volume":"99","author":"M Cellini","year":"2014","unstructured":"M. Cellini, M.G. Santaguida, I. Gatto, C. Virili, S.C. Del Duca, N. Brusca, S. Capriello, L. Gargano, M. Centanni, Systematic appraisal of lactose intolerance as cause of increased need for oral thyroxine. J. Clin. Endocrinol. Metab. 99(8), E1454\u2013E1458 (2014). https:\/\/doi.org\/10.1210\/jc.2014-1217","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"10","key":"3056_CR36","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1097\/00000478-199610000-00001","volume":"20","author":"MF Dixon","year":"1996","unstructured":"M.F. Dixon, R.M. Genta, J.H. Yardley, P. Correa, Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am. J. Surg. Pathol. 20(10), 1161\u20131181 (1996). https:\/\/doi.org\/10.1097\/00000478-199610000-00001","journal-title":"Am. J. Surg. Pathol."},{"issue":"10","key":"3056_CR37","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1136\/gutjnl-2014-307595","volume":"64","author":"RH Hunt","year":"2015","unstructured":"R.H. Hunt, M. Camilleri, S.E. Crowe, E.M. El-Omar, J.G. Fox, E.J. Kuipers, P. Malfertheiner, K.E. McColl, D.M. Pritchard, M. Rugge, A. Sonnenberg, K. Sugano, J. Tack, The stomach in health and disease. Gut 64(10), 1650\u20131668 (2015). https:\/\/doi.org\/10.1136\/gutjnl-2014-307595","journal-title":"Gut"},{"issue":"6","key":"3056_CR38","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/j.bpg.2014.10.006","volume":"28","author":"F Di Mario","year":"2014","unstructured":"F. Di Mario, E. Goni, Gastric acid secretion: changes during a century. Best Pract. Res. Clin. Gastroenterol. 28(6), 953\u2013965 (2014). https:\/\/doi.org\/10.1016\/j.bpg.2014.10.006","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"issue":"4","key":"3056_CR39","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1136\/gut.52.4.496","volume":"52","author":"B Annibale","year":"2003","unstructured":"B. Annibale, G. Capurso, E. Lahner, S. Passi, R. Ricci, F. Maggio, G. Delle Fave, Concomitant alterations in intragastric pH and ascorbic acid concentration in patients with Helicobacter pylori gastritis and associated iron deficiency anaemia. Gut 52(4), 496\u2013501 (2003). https:\/\/doi.org\/10.1136\/gut.52.4.496","journal-title":"Gut"},{"issue":"6","key":"3056_CR40","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1210\/endo-89-6-1376","volume":"89","author":"A Gordon","year":"1971","unstructured":"A. Gordon, T. Coutsoftides, The effect of blood pH on the acute distribution of thyroxine in the rat. Endocrinology 89(6), 1376\u20131379 (1971). https:\/\/doi.org\/10.1210\/endo-89-6-1376","journal-title":"Endocrinology"},{"issue":"4","key":"3056_CR41","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1210\/edrv.22.4.0435.","volume":"22","author":"G Hennemann","year":"2001","unstructured":"G. Hennemann, R. Docter, E.C. Friesema, M. de Jong, E.P. Krenning, T.J. Visser, Plasma membrane transport of thyroid hormones and its role in thyroid hormone metabolism and bioavailability. Endocr. Rev. 22(4), 451\u2013476 (2001). https:\/\/doi.org\/10.1210\/edrv.22.4.0435.","journal-title":"Endocr. Rev."},{"issue":"1","key":"3056_CR42","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.ejpb.2008.10.008","volume":"72","author":"D Pabla","year":"2009","unstructured":"D. Pabla, F. Akhlaghi, H. Zia, A comparative pH-dissolution profile study of selected commercial levothyroxine products using inductively coupled plasma mass spectrometry. Eur. J. Pharm. Biopharm. 72(1), 105\u2013110 (2009). https:\/\/doi.org\/10.1016\/j.ejpb.2008.10.008","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"6","key":"3056_CR43","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1007\/s11095-016-1882-8","volume":"33","author":"C Litou","year":"2016","unstructured":"C. Litou, M. Vertzoni, C. Goumas, V. Vasdekis, W. Xu, F. Kesisoglou, C. Reppas, Characteristics of the human upper gastrointestinal contents in the fasted state under hypo- and a-chlorhydric gastric conditions under conditions of typical drug - drug interaction studies. Pharm. Res. 33(6), 1399\u20131412 (2016). https:\/\/doi.org\/10.1007\/s11095-016-1882-8","journal-title":"Pharm. Res."},{"key":"3056_CR44","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.3389\/fphys.2019.01566","volume":"10","author":"L Cao","year":"2020","unstructured":"L. Cao, Z. Yuan, M. Liu, C. Stock, (Patho-)Physiology of Na+\/H+ exchangers (NHEs) in the Digestive system. Front. Physiol. 10, 1566 (2020). https:\/\/doi.org\/10.3389\/fphys.2019.01566","journal-title":"Front. Physiol."},{"issue":"6","key":"3056_CR45","doi-asserted-by":"publisher","first-page":"e0218274","DOI":"10.1371\/journal.pone.0218274","volume":"14","author":"NR Dash","year":"2019","unstructured":"N.R. Dash, G. Khoder, A.M. Nada, M.T. Al Bataineh, Exploring the impact of Helicobacter pylori on gut microbiome composition. PLoS ONE 14(6), e0218274 (2019). https:\/\/doi.org\/10.1371\/journal.pone.0218274","journal-title":"PLoS ONE"},{"issue":"22","key":"3056_CR46","doi-asserted-by":"publisher","first-page":"2706","DOI":"10.3748\/wjg.v25.i22.2706","volume":"25","author":"G Bruno","year":"2019","unstructured":"G. Bruno, P. Zaccari, G. Rocco, G. Scalese, C. Panetta, B. Porowska, S. Pontone, C. Severi, Proton pump inhibitors and dysbiosis: Current knowledge and aspects to be clarified. World J. Gastroenterol. 25(22), 2706\u20132719 (2019). https:\/\/doi.org\/10.3748\/wjg.v25.i22.2706","journal-title":"World J. Gastroenterol."},{"issue":"2","key":"3056_CR47","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1136\/gut.42.2.266","volume":"42","author":"K Shindo","year":"1998","unstructured":"K. Shindo, M. Machida, M. Fukumura, K. Koide, R. Yamazaki, Omeprazole induces altered bile acid metabolism. Gut 42(2), 266\u2013271 (1998). https:\/\/doi.org\/10.1136\/gut.42.2.266","journal-title":"Gut"},{"issue":"1","key":"3056_CR48","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/j.1574-6968.1988.tb02709.x-i1","volume":"4","author":"MP Hazenberg","year":"1988","unstructured":"M.P. Hazenberg, W.W. de Herder, T.J. Visser, Hydrolysis of iodothyronine conjugates by intestinal bacteria. FEMS Microbiol. Rev. 4(1), 9\u201316 (1988). https:\/\/doi.org\/10.1111\/j.1574-6968.1988.tb02709.x-i1","journal-title":"FEMS Microbiol. Rev."},{"key":"3056_CR49","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.mce.2017.01.053","volume":"458","author":"C Virili","year":"2017","unstructured":"C. Virili, M. Centanni, \u201cWith a little help from my friends\u201d - The role of microbiota in thyroid hormone metabolism and enterohepatic recycling. Mol. Cell. Endocrinol. 458, 39\u201343 (2017). https:\/\/doi.org\/10.1016\/j.mce.2017.01.053","journal-title":"Mol. Cell. Endocrinol."},{"issue":"5","key":"3056_CR50","doi-asserted-by":"publisher","first-page":"844","DOI":"10.18433\/j36p5m","volume":"18","author":"C Seng Yue","year":"2015","unstructured":"C. Seng Yue, S. Benvenga, C. Scarsi, L. Loprete, M.P. Ducharme, When bioequivalence in healthy volunteers may not translate to bioequivalence in patients: differential effects of increased gastric ph on the pharmacokinetics of levothyroxine capsules and tablets. J. Pharm. Pharm. Sci. 18(5), 844\u2013855 (2015). https:\/\/doi.org\/10.18433\/j36p5m","journal-title":"J. Pharm. Pharm. Sci."},{"issue":"6","key":"3056_CR51","doi-asserted-by":"publisher","first-page":"E1031","DOI":"10.1210\/jc.2013-4360","volume":"99","author":"W Jubiz","year":"2014","unstructured":"W. Jubiz, M. Ramirez, Effect of vitamin C on the absorption of levothyroxine in patients with hypothyroidism and gastritis. J. Clin. Endocrinol. Metab. 99(6), E1031\u2013E1034 (2014). https:\/\/doi.org\/10.1210\/jc.2013-4360","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"3056_CR52","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1089\/thy.2017.0428","volume":"28","author":"DA Chon","year":"2018","unstructured":"D.A. Chon, T. Reisman, J.E. Weinreb, J.M. Hershman, A.M. Leung, Concurrent milk ingestion decreases absorption of levothyroxine. Thyroid 28(4), 454\u2013457 (2018). https:\/\/doi.org\/10.1089\/thy.2017.0428","journal-title":"Thyroid"},{"issue":"5","key":"3056_CR53","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1089\/thy.2010.0296","volume":"21","author":"I Zamfirescu","year":"2011","unstructured":"I. Zamfirescu, H.E. Carlson, Absorption of levothyroxine when coadministered with various calcium formulations. Thyroid 21(5), 483\u2013486 (2011). https:\/\/doi.org\/10.1089\/thy.2010.0296","journal-title":"Thyroid"},{"key":"3056_CR54","doi-asserted-by":"publisher","first-page":"621616","DOI":"10.3389\/fendo.2020.621616","volume":"11","author":"C Virili","year":"2021","unstructured":"C. Virili, N. Brusca, S. Capriello, M. Centanni, Levothyroxine therapy in gastric malabsorptive disorders. Front. Endocrinol. 11, 621616 (2021). https:\/\/doi.org\/10.3389\/fendo.2020.621616","journal-title":"Front. Endocrinol."},{"issue":"7","key":"3056_CR55","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1053\/j.gastro.2008.05.021","volume":"134","author":"ML Schubert","year":"2008","unstructured":"M.L. Schubert, D.A. Peura, Control of gastric acid secretion in health and disease. Gastroenterology 134(7), 1842\u20131860 (2008). https:\/\/doi.org\/10.1053\/j.gastro.2008.05.021","journal-title":"Gastroenterology"},{"issue":"4","key":"3056_CR56","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.dld.2010.10.012","volume":"43","author":"L Vannella","year":"2011","unstructured":"L. Vannella, E. Lahner, C. Bordi, E. Pilozzi, E. Di Giulio, V.D. Corleto, J. Osborn, G. Delle Fave, B. Annibale, Reversal of atrophic body gastritis after H. pylori eradication at long-term follow-up. Dig. Liver Dis. 43(4), 295\u2013299 (2011). https:\/\/doi.org\/10.1016\/j.dld.2010.10.012","journal-title":"Dig. Liver Dis."},{"issue":"1","key":"3056_CR57","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s12020-019-02049-x","volume":"66","author":"C Virili","year":"2019","unstructured":"C. Virili, P. Trimboli, M. Centanni, Novel thyroxine formulations: a further step toward precision medicine. Endocrine 66(1), 87\u201394 (2019). https:\/\/doi.org\/10.1007\/s12020-019-02049-x","journal-title":"Endocrine"},{"key":"3056_CR58","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s12876-016-0439-y","volume":"16","author":"P Fallahi","year":"2016","unstructured":"P. Fallahi, S.M. Ferrari, I. Ruffilli, A. Antonelli, Reversible normalisation of serum TSH levels in patients with autoimmune atrophic gastritis who received L-T4 in tablet form after switching to an oral liquid formulation: a case series. BMC Gastroenterol. 16, 22 (2016). https:\/\/doi.org\/10.1186\/s12876-016-0439-y","journal-title":"BMC Gastroenterol."},{"issue":"1","key":"3056_CR59","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s12020-014-0476-7","volume":"49","author":"MG Santaguida","year":"2015","unstructured":"M.G. Santaguida, C. Virili, S.C. Del Duca, M. Cellini, I. Gatto, N. Brusca, C. De Vito, L. Gargano, M. Centanni, Thyroxine softgel capsule in patients with gastric-related T4 malabsorption. Endocrine 49(1), 51\u201357 (2015). https:\/\/doi.org\/10.1007\/s12020-014-0476-7","journal-title":"Endocrine"},{"issue":"3","key":"3056_CR60","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1007\/s12020-016-1167-3","volume":"57","author":"D Ribichini","year":"2017","unstructured":"D. Ribichini, G. Fiorini, A. Repaci, V. Castelli, L. Gatta, D. Vaira, R. Pasquali, Tablet and oral liquid L-thyroxine formulation in the treatment of na\u00efve hypothyroid patients with Helicobacter pylori infection. Endocrine 57(3), 394\u2013401 (2017). https:\/\/doi.org\/10.1007\/s12020-016-1167-3","journal-title":"Endocrine"},{"issue":"12","key":"3056_CR61","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1089\/thy.2013.0661","volume":"24","author":"HM Robertson","year":"2014","unstructured":"H.M. Robertson, A.K. Narayanaswamy, O. Pereira, S.A. Copland, R. Herriot, A.W. McKinlay, J.S. Bevan, P. Abraham, Factors contributing to high levothyroxine doses in primary hypothyroidism: an interventional audit of a large community database. Thyroid 24(12), 1765\u20131771 (2014). https:\/\/doi.org\/10.1089\/thy.2013.0661","journal-title":"Thyroid"},{"issue":"2","key":"3056_CR62","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s12020-019-02185-4","volume":"67","author":"M Castellana","year":"2020","unstructured":"M. Castellana, C. Castellana, L. Giovanella, P. Trimboli, Prevalence of gastrointestinal disorders having an impact on tablet levothyroxine absorption: should this formulation still be considered as the first-line therapy? Endocrine 67(2), 281\u2013290 (2020). https:\/\/doi.org\/10.1007\/s12020-019-02185-4","journal-title":"Endocrine"},{"issue":"4","key":"3056_CR63","doi-asserted-by":"publisher","first-page":"563","DOI":"10.3748\/wjg.14.563","volume":"14","author":"E Lahner","year":"2008","unstructured":"E. Lahner, M. Intraligi, M. Buscema, M. Centanni, L. Vannella, E. Grossi, B. Annibale, Artificial neural networks in the recognition of the presence of thyroid disease in patients with atrophic body gastritis. World J. Gastroenterol. 14(4), 563\u2013568 (2008). https:\/\/doi.org\/10.3748\/wjg.14.563","journal-title":"World J. Gastroenterol."},{"issue":"1","key":"3056_CR64","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s12020-019-02049-x","volume":"37","author":"FR Ernst","year":"2017","unstructured":"F.R. Ernst, P. Barr, R. Elmor, W. Sandulli, L. Thevathasan, A.B. Sterman, J. Goldenberg, K. Vora, The economic impact of levothyroxine dose adjustments: the CONTROL HE study. Clin. Drug. Investig. 37(1), 71\u201383 (2017). https:\/\/doi.org\/10.1007\/s12020-019-02049-x","journal-title":"Clin. Drug. Investig."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-022-03056-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-022-03056-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-022-03056-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,20]],"date-time":"2022-07-20T17:17:53Z","timestamp":1658337473000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-022-03056-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,27]]},"references-count":64,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["3056"],"URL":"https:\/\/doi.org\/10.1007\/s12020-022-03056-1","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,27]]},"assertion":[{"value":"11 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"M.C. was invited lecturer in international symposia and received honorarium from Institut Biochimique SA (IBSA), Pambio Noranco, CH. The other authors have no conflicts to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}